Weekly paclitaxel/cisplatin with concurrent radiotherapy in patients with locally advanced non-small cell lung cancer: A phase I study

Seminars in Oncology

Volumn 24, Issue 4 SUPPL.12, 1997, Pages

  Comella, G ^a   Frasci, G ^a   Scoppa, G ^a   Guida, C ^a   Gravina, A ^a   Fiore, F ^a   Casaretti, R ^a   Daponte, A ^a   Ruffolo, P ^a   Comella, P ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; ESOPHAGITIS; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; AGED; ARTICLE; DRUG ADMINISTRATION; LUNG TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RADIATION DOSE; SURVIVAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS;

EID: 17144465247     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)